Although the incidence of hepatocellular carcinoma (HCC) occurring after hepatitis C virus
(HCV) eradication has decreased, there are still reports of hepatocarcinogenesis. The …

Objective We attempted to elucidate the clinical features of chronic hepatitis C patients who
develop hepatocellular carcinoma (HCC) after achieving a sustained viral response (SVR) …

Interferon (IFN) therapy decreases the incidence of hepatocellular carcinoma (HCC) in
patients with hepatitis C virus (HCV). One hundred and fifty‐nine consecutive patients who …

Background Interferon (IFN) reduces the risk of hepatocellular carcinoma (HCC) in patients
with chronic hepatitis C (CHC). However, HCC develops in the some patients who have …

Aim: Several investigators have shown that interferon (IFN) therapy can suppress the
recurrence of hepatocellular carcinoma (HCC) after curative treatment. We investigated the …

To evaluate the effect of interferon (IFN) therapy on the development of hepatocellular car
cinoma (HCC) and the risk factors for HCC after treatment, we retrospectively studied 193 …

The results of liver resection for hepatitis C virus (HCV)-related hepatocellular carcinoma
(HCC) are affected by persistent active hepatitis and/or hepatic fibrosis including cirrhosis. In …

Background: Although a variety of papers demonstrated inhibited hepatocarcinogenesis
with interferon (IFN) therapy for chronic hepatitis C, a small number of hepatocellular …

Background We evaluated the clinical features and the prognostic factors of hepatocellular
carcinoma (HCC) developed after hepatitis C virus (HCV) eradication with interferon (IFN) …

Background: We first reported that interferon (IFN) prevent hepatocarcinogenesis in patients
with chronic active hepatitis C with cirrhosis in 1995. However, even in the patients who …